Cargando…
Safety and efficacy of Qurse-e-istisqua in chronic hepatitis C Infection: An exploratory study
BACKGROUND: Qurse-e-istisqua (Q-e-I), an Unani medicine commonly prescribed to treat liver disorders. OBJECTIVES: To study efficacy and safety of Q-e-I in hepatitis C virus (HCV) infection. METHODS: In this randomized double-blind exploratory study, 60 naive patients of HCV infection were assigned t...
Autores principales: | Rehan, Harmeet Singh, Chopra, Deepti, Yadav, Madhur, Wardhan, Neeta, Manak, Seema, Siddiqui, KM, Aslam, Mohd. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375823/ https://www.ncbi.nlm.nih.gov/pubmed/25821315 http://dx.doi.org/10.4103/0253-7613.150347 |
Ejemplares similares
-
Diversity of Genotype and Mode of Spread of Hepatitis C Virus in Northern India
por: Rehan, Harmeet S., et al.
Publicado: (2011) -
Supervised conventional interferon α2a in combination with ribavirin therapy is the preferred alternative for treatment of chronic hepatitis C
por: Rehan, Harmeet Singh, et al.
Publicado: (2014) -
Standardization of Unani Antidiabetic Tablet - Qurse Tabasheer
por: Ali, Waris, et al.
Publicado: (2016) -
IFN-α-2a (Interferon) and ribavirin induced suicidal attempt in a patient of chronic HCV: A rare case report
por: Inder, Deep, et al.
Publicado: (2011) -
Chemotherapy-induced adverse drug reactions in oncology patients: A prospective observational survey
por: Chopra, Deepti, et al.
Publicado: (2016)